Sernova (SEOVF) News Today → Guard Against the Coming Financial Upheaval (From Porter & Company) (Ad) Free SEOVF Stock Alerts $0.24 -0.01 (-4.08%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 2:09 AM | americanbankingnews.comSernova (OTCMKTS:SEOVF) Shares Down 3.7% May 1, 2024 | finance.yahoo.comSernova Announces AGM Voting ResultsApril 26, 2024 | marketbeat.comSernova Corp. (OTCMKTS:SEOVF) Short Interest UpdateSernova Corp. (OTCMKTS:SEOVF - Get Free Report) was the recipient of a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 1,900 shares, a decline of 98.2% from the March 31st total of 106,700 shares. Based on an average daily trading volume, of 41,900 shares, the short-interest ratio is currently 0.0 days.March 11, 2024 | marketwatch.comSernova Names Nicholas Rossettos Interim CFOJanuary 29, 2024 | msn.comSernova reports anticipated 2024 milestonesNovember 27, 2023 | msn.comSernova gets FDA orphan drug, rare pediatric designations for hemophilia ANovember 14, 2023 | theglobeandmail.comClosing Bell: Sernova Corp flat on Tuesday (SVA)October 30, 2023 | finance.yahoo.comSernova Announces New Advancements of Conformal Coating Technology in Combination with the Cell Pouch System™ at the 2023 IPITA-IXA-CTRMS Joint CongressSeptember 29, 2023 | finance.yahoo.comSernova Presents Compelling New Data on the Cell Pouch System™ as a Promising Treatment for Post-Operative Hypothyroidism at the 2023 American Thyroid Association Annual MeetingSeptember 7, 2023 | finance.yahoo.comSernova Provides Development Update on Proprietary Cellular Conformal Coating Technology in Combination with Cell Pouch DeviceSeptember 5, 2023 | marketwatch.comSernova Appoints Cynthia Pussinen as Chief ExecutiveSeptember 5, 2023 | seekingalpha.comSernova appoints CEOJune 26, 2023 | markets.businessinsider.comSernova (SVA) Receives a Buy from H.C. WainwrightJune 22, 2023 | finance.yahoo.comSernova to Present Updated Interim Phase 1/2 Clinical Data on Cell Pouch System™ During Oral Presentation at American Diabetes Association 83rd Scientific SessionsJune 16, 2023 | finance.yahoo.comSernova to Participate in Upcoming Truist Securities Cell Therapy SymposiumJune 15, 2023 | markets.businessinsider.comEchelon Wealth Partners Remains a Buy on Sernova (SVA)May 31, 2023 | finance.yahoo.comSernova Announces Executive Alignment and Appoints New Board ChairMay 8, 2023 | theglobeandmail.comClosing Bell: Sernova Corp flat on Monday (SVA)April 28, 2023 | theglobeandmail.comClosing Bell: Sernova Corp flat on Thursday (SVA)April 25, 2023 | finance.yahoo.comConcerned Shareholders of Sernova Corp. Wish to Thank All ShareholdersApril 10, 2023 | finance.yahoo.comSernova to Present at 2023 Alliance for Regenerative Medicine Cell & Gene Meeting on the MedApril 6, 2023 | finanznachrichten.deSernova Corp.: Sernova Responds to Dissident Shareholders' Misleading Statements and Provides Corporate UpdatesMarch 23, 2023 | finance.yahoo.comAdvance Notice Filed with Sernova Corp. for the Nomination of Two Director NomineesMarch 22, 2023 | finance.yahoo.comSernova Announces Abstract on First Cohort of its Phase 1/2 Study Involving Islet Allotransplantation into Pre-vascularized Cell Pouch™ Selected for Oral Podium Presentation at American Diabetes Association 83rd Scientific Sessions 2023March 2, 2023 | finance.yahoo.comSernova to Participate in Upcoming Roth and Oppenheimer Investor ConferencesJanuary 30, 2023 | marketwatch.comSernova Shares Climb After Study Update on System to Preserve Thyroid FunctionJanuary 30, 2023 | uk.news.yahoo.comSernova Announces Advancements with its Novel Cell Pouch System(TM) to Preserve Thyroid Function Following Total ThyroidectomyJanuary 30, 2023 | finance.yahoo.comSernova Announces Advancements with its Novel Cell Pouch System™ to Preserve Thyroid Function Following Total ThyroidectomyJanuary 30, 2023 | finance.yahoo.comSernova Announces Advancements with its Novel Cell Pouch System™ to Preserve Thyroid Function Following Total ThyroidectomyDecember 6, 2022 | marketwatch.comSernova Begins Search for New CEO; Toleikis to Transition to CTODecember 6, 2022 | finance.yahoo.comSernova Corp. Announces CEO Succession Plan and Expanded Management TeamSeptember 8, 2022 | finance.yahoo.comSernova to Present at H.C. Wainwright Annual Global Investment Conference and LifeSci Partners HealthTech SymposiumSeptember 7, 2022 | finance.yahoo.comSernova Announces the Appointment of Daniel Mahony, Ph.D. to its Board of DirectorsAugust 30, 2022 | finance.yahoo.comSernova to Participate in Live Investor Event Hosted by Leede Jones Gable, Inc.June 8, 2022 | stockhouse.comSernova Announces Positive Updated Phase 1/2 Clinical Data on Cell Pouch System(TM) at American Diabetes Association 82nd Scientific Sessions 2022June 7, 2022 | apnews.comSernova Announces Positive Updated Phase 1/2 Clinical Data on Cell Pouch System™ at American Diabetes Association 82nd Scientific Sessions 2022May 24, 2022 | stockhouse.comSernova Receives Conditional Approval to Up-list to the Toronto Stock ExchangeMay 17, 2022 | seekingalpha.comEvotec teams up with Sernova to develop diabetes therapy, commits €20M equity investmentMay 17, 2022 | finance.yahoo.comSernova and Evotec Enter into an Exclusive Global Strategic Partnership for iPSC-Based Beta Cell Replacement Therapy to Develop and Commercialize a ‘Functional Cure’ for DiabetesApril 30, 2022 | stockhouse.comSernova Announces 2022 Annual General Meeting ResultsFebruary 24, 2022 | stockhouse.comSernova Corp Ranks Among Top 50 Performing Companies on the 2022 TSX Venture ListJanuary 5, 2022 | uk.finance.yahoo.comSernova to Announce New Interim Results of its Type 1 Diabetes Clinical Trial During the 40th Annual J.P. Morgan Healthcare ConferenceDecember 16, 2021 | stockhouse.comSernova Announces Clinical Investigator Update of its Type 1 Diabetes Trial at the 2022 ASTS 22nd Annual Winter SymposiumOctober 15, 2021 | stockhouse.comSernova: The Ultimate Combination of Two Proven Technologies as Potential Functional Cure for Type 1 Diabetes and Other Chronic DiseasesAugust 13, 2021 | stockhouse.comSernova to Present Corporate Update at Canaccord Genuity's 41st Annual Growth Conference Get Sernova News Delivered to You Automatically Sign up to receive the latest news and ratings for SEOVF and its competitors with MarketBeat's FREE daily newsletter. Email Address Guard Against the Coming Financial Upheaval (Ad)America’s Most Shocking Financial Story… Behind closed doors in D.C., there is a dark political and economic plot underway. That’s why if you have any savings in the bank or own any assets you want to protect, you must watch this new documentary before it’s too late. You can stream it for free right here. SEOVF Media Mentions By Week SEOVF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SEOVF News Sentiment▼0.670.42▲Average Medical News Sentiment SEOVF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SEOVF Articles This Week▼10▲SEOVF Articles Average Week Get Sernova News Delivered to You Automatically Sign up to receive the latest news and ratings for SEOVF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VACC News Today BTAI News Today MRNS News Today BRNS News Today CMRX News Today SPRO News Today ONCY News Today CNTB News Today PRPH News Today CRVS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SEOVF) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersDon’t expose yourself to stocks during the weekDTIRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHas Trump Finally Gone Too Far?Insiders ExposedDoes this make you sick?Allegiance GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaHow this is some devastating newsWealthPress Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sernova Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
